Characteristics of patients
| Characteristic | N, % (range) |
| Total no of patients | 18 |
| Age, median (range), years | 40.5 (31–57) |
| BMI (median, range), kg/m2 | 23.5 (19–33) |
| Surgical approach, n (%) | |
| Laparotomy | 3 (16.7) |
| Laparoscopy | 12 (66.6) |
| Robotic | 3 (16.7) |
| Histology, n (%) | |
| Squamous cell carcinoma | 10 (55.5) |
| Adenocarcinoma | 8 (44.5) |
| Grade, n (%) | |
| 1 | 2 (11.1) |
| 2 | 10 (55.5) |
| 3 | 4 (22.2) |
| Unknown | 2 (11.1) |
| Lymph vascular space invasion, n (%) | |
| No | 9 (50.0) |
| Yes | 8 (44.5) |
| Not reported | 1 (5.5) |
| Tumor size, median (range), mm | 16.5 (1–34) |
| Tumor ≥20 mm, n (%) | |
| Yes | 7 (38.9) |
| No | 11 (61.1) |
| FIGO (2009) stage, n (%) | |
| IA1 | 1 (5.5) |
| IB1 | 17 (94.5) |
| Prior cervical conization, n (%) | |
| Yes | 8 (44.5) |
| No | 10 (55.5) |
| SLN mapping | |
| Unilateral | 4 (22.2) |
| Bilateral | 14 (77.8) |
| SLN metastasis | |
| No | 12 (66.7) |
| Isolated tumor cells | 0 |
| Micro-metastasis | 6 (33.3) |
| Macro-metastasis | 0 |
| Median follow-up (range), months | 11 (4–21) |
| Recurrence | |
| Yes | 0 |
| No | 18 (100.0) |
BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; SLN, sentinel lymph node.